Home › Funds › COOKE & BIELER LP › LH

COOKE & BIELER LP position in LH

LABCORP HOLDINGS INC · Health Care

COOKE & BIELER LP reported holding 490,641 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$151.2M, representing 2.38% of its reported portfolio and ranking #8 among its reported holdings. COOKE & BIELER LP has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)490.64K sh
Reported value held$151.17M
Portfolio Weight2.38%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How COOKE & BIELER LP's LH position evolved

COOKE & BIELER LP first disclosed a stake in LH in Q3 2023 at 689,716 shares (US$138.7M). The position peaked in Q3 2025 at 754,449 shares, worth US$216.6M. Across 13 filings, COOKE & BIELER LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 490,641 shares valued at US$151.2M — a reduction of -178,537 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2024 (shares rose 10% over the following quarter), a 27% trim in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 689.72K $138.67M New
Q4 2023 672.35K $152.82M Reduce
Q1 2024 732.13K $159.94M Add
Q2 2024 928.25K $188.91M Add
Q3 2024 942.10K $210.54M Add
Q4 2024 848.26K $194.52M Reduce
Q1 2025 833.22K $193.92M Reduce
Q2 2025 817.93K $214.72M Reduce
Q3 2025 754.45K $216.57M Reduce
Q4 2025 752.92K $188.89M Hold
Q1 2026 674.02K $179.84M Reduce
Q2 2026 669.18K $187.37M Reduce
Q3 2026 490.64K $151.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has COOKE & BIELER LP held LH?

COOKE & BIELER LP has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is COOKE & BIELER LP's current position in LH?

As of Q3 2026, COOKE & BIELER LP holds 490.64K shares of LH (LABCORP HOLDINGS INC), valued at $151.17M, representing 2.38% of its reported portfolio and ranking #8.

Has COOKE & BIELER LP been buying or selling LH?

In the latest 13F filing (Q3 2026), COOKE & BIELER LP reduced its position in LH. The position peaked in Q3 2025 at 754.45K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.